Item Type | Name |
Concept
|
Antigen-Presenting Cells
|
Concept
|
Histocompatibility Antigens Class II
|
Concept
|
Antigens, Ly
|
Concept
|
Antigens, Neoplasm
|
Concept
|
Antigens, Viral
|
Concept
|
H-2 Antigens
|
Concept
|
HLA-DR Antigens
|
Concept
|
Receptors, Antigen, B-Cell
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
Histocompatibility Antigens Class I
|
Concept
|
HIV Antigens
|
Concept
|
Antigens, CD
|
Concept
|
HLA-A1 Antigen
|
Concept
|
HLA-A2 Antigen
|
Concept
|
Antigen Presentation
|
Academic Article
|
Mucosally restricted antigens as novel immunological targets for antitumor therapy.
|
Academic Article
|
Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin.
|
Academic Article
|
Cutting Edge: Selective role of ubiquitin in MHC class I antigen presentation.
|
Academic Article
|
Hydrophobicity as a driver of MHC class I antigen processing.
|
Academic Article
|
Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation.
|
Academic Article
|
Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.
|
Academic Article
|
Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum.
|
Academic Article
|
The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope.
|
Academic Article
|
A thyroid tumor-specific antigen formed by the fusion of two self proteins.
|
Academic Article
|
Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification.
|
Academic Article
|
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein.
|
Academic Article
|
Vaccinia virus as a tool for immunologic studies.
|
Academic Article
|
Differential requirements for endosomal reduction in the presentation of two H2-E(d)-restricted epitopes from influenza hemagglutinin.
|
Academic Article
|
A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent.
|
Academic Article
|
The impact of misfolding versus targeted degradation on the efficiency of the MHC class I-restricted antigen processing.
|
Academic Article
|
Antigen processing and presentation.
|
Academic Article
|
Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2.
|
Academic Article
|
Re-evaluating the generation of a "proteasome-independent" MHC class I-restricted CD8 T cell epitope.
|
Academic Article
|
Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins.
|
Academic Article
|
Epitopes derived by incidental translational frameshifting give rise to a protective CTL response.
|
Academic Article
|
Immunogenicity of cytopathic and noncytopathic viral vectors.
|
Academic Article
|
Human T-cell responses to vaccinia virus envelope proteins.
|
Academic Article
|
Oncogenic inflammation and autoimmune disease.
|
Academic Article
|
Rethinking peptide supply to MHC class I molecules.
|
Academic Article
|
Derivation and fluidity of acutely induced dysfunctional CD8+ T cells.
|
Academic Article
|
Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease.
|
Academic Article
|
Cytokine adjuvanation of therapeutic anti-tumor immunity targeted to cancer mucosa antigens.
|
Academic Article
|
Toward a Network Model of MHC Class II-Restricted Antigen Processing.
|
Academic Article
|
Endogenous antigen processing drives the primary CD4(+) T cell response to influenza.
|
Academic Article
|
Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation.
|
Academic Article
|
Editorial overview: Antigen processing.
|
Grant
|
IMPACT OF EPITOPE DENSITY ON TCD8, ACTIVATION AND MEMORY
|
Grant
|
The RET/PTC3 Oncogene: Antigenic and Inflammatory Properties
|
Grant
|
Non-proteasomal protease(s) that define C-termini of MHC class I epitopes
|
Grant
|
Alternative MHCII Processing of Influenza Virus Proteins
|
Grant
|
Class II Processing and Presentation During Secondary Responses to Influenza
|
Grant
|
MHCII Cross-presentation as a Driver of CD4+ T Cell Responses to Poxviruses
|
Grant
|
Dissecting 3 processing pathways that generate class II-restricted flu epitopes
|
Grant
|
Alternative Pathways for CD4+ T Cell Epitope Generation from Influenza Antigens
|
Grant
|
Dynamics of tolerance induction to tumor associated antigens
|
Grant
|
Accessing the MHC Class I Processing Pathway
|
Grant
|
Class II Processing Delineated by Flu Glycoproteins
|
Grant
|
The Basis for MHC Class II-restricted proteasome-dependent epitopes
|
Grant
|
Antigen stability as a parameter in rational T(CD8+)-targeting vaccine design
|
Academic Article
|
The elucidation of non-classical MHC class II antigen processing through the study of viral antigens.
|
Grant
|
Major contribution of non-classical antigen processing to Salmonella Typhimurium-specific CD4+ T cell responses
|
Academic Article
|
CD8 + T-cell responses in vaccination: reconsidering targets and function in the context of chronic antigen stimulation.
|
Grant
|
Defining the MHC-II processing and presentation landscape of HIV-1
|
Academic Article
|
Poor Antigen Processing of Poxvirus Particles Limits CD4+ T Cell Recognition and Impacts Immunogenicity of the Inactivated Vaccine.
|
Academic Article
|
Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.
|
Grant
|
Delineating the non-conventional MHC class I and class II peptidome of influenza
|
Academic Article
|
Ectromelia-encoded virulence factor C15 specifically inhibits antigen presentation to CD4+ T cells post peptide loading.
|
Academic Article
|
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation.
|
Academic Article
|
Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation.
|
Academic Article
|
Regulation of the BCR signalosome by the class II peptide editor, H2-M, affects the development and repertoire of innate-like B cells.
|